2009 Community Patients Physicals 
The Clinical Problem Solvers
DECEMBER 16, 2020
19:05 Clarifying the “ethics vs science” argument and critiquing research techniques 22:00 Resurgence of race-based speculation in COVID-19-related research 25:57 Implantation of ideas about innate racial inferiority within medicine 28:32 Will removal of race from algorithms potentially harm our patients?
GeriPal
OCTOBER 13, 2022
When I’m on service these days there is inevitably a moment when a resident says “Patient so-and-so is on X” – and I have absolutely no idea what X is. Alex: And we are delighted to welcome Rasheeda Hall, who is a physician scientist in the division of nephrology at Duke University School of Medicine, and sees patients at the Durham VA.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
GeriPal
MARCH 2, 2023
The FDA-approved indications for gabapentin are only for treating patients with partial seizures or postherpetic neuralgia. valproic acid and gabapentin), in nursing homes, particularly patients with Alzheimer’s disease and related dementias. There are a lot of reasons that may explain the massive increase in use of these drugs.
GeriPal
OCTOBER 20, 2022
And, who within ASPE guides aging policy and connects policy to every day health challenges experienced by patients and clinicians? How HHS and ASPE solicit input from clinicians, community leaders, and older adults and how much it impacts policy decisions (spoiler alert: this involvement is CRUCIAL). Sonali: Thank you for having me.
GeriPal
MARCH 10, 2022
Many years ago for the first study; I believe it was in 2009, 2010; I met with Susan Mitchell at the Institute for Aging Research, and told her that I wanted to study the use of feeding tubes for people with advanced dementia. What does the physical environment look like? My question is, why this study, and why now? Ruth: Sure.
Expert insights. Personalized for you.
52 
Let's personalize your content